webinar register page

Webinar banner
RSC Desktop Seminar Lectureship series with RSC Medicinal Chemistry
Welcome to the RSC Medicinal Chemistry Lectureship webinar, hosted by RSC Medicinal Chemistry.

This 90 minute seminar will feature scientific talks from the 2021 and 2022 RSC Medicinal Chemistry Emerging Lectureship recipients, Dr Jacob Bush and Dr Nir London, with an introduction by RSC Medicinal Chemistry Executive Editor, Becky Garton.

Dr Jacob Bush
GSK & Francis Crick Institute, UK
2021 RSC Medicinal Chemistry Emerging Investigator Lectureship recipient
Talk title: "Reactive fragment platforms for expansion of the liganded proteome"

Dr Nir London
Weizmann Institute of Science, Israel
2022 RSC Medicinal Chemistry Emerging Investigator Lectureship recipient
Talk title: “Covalent Ligand Directed Release Chemistry”

For more information, please visit the event page at:
https://www.rsc.org/events/detail/74439/rsc-desktop-seminar-lectureship-series-with-rsc-medicinal-chemistry

01:26:00

Webinar logo
* Required information
Loading
By registering for this webinar you acknowledge that: You have read, understood and accept the terms of use (Click Here). You have read, understood and accept our Event/Conference booking terms and conditions (Click Here). We need to collect and manage your personal data in order to provide this service. Our privacy statement explains how we do this (Click Here).

Speakers

Dr Jacob Bush
Director of Chemical Biology @GSK & Francis Crick Institute
Recipient of the 2021 RSC Medicinal Chemistry Emerging Investigator Lectureship. Dr Jacob Bush is a Director in the Chemical Biology Department at GSK and sits on the leadership team of the GSK-Francis Crick Institute Biomedical LinkLabs collaboration. Prior to joining GSK, Jake completed a degree in chemistry from the University of Oxford and a DPhil in chemical biology in the laboratory of Professor Christopher Schofield. With an interest for translational science, he joined GSK in 2015 to explore ways to accelerate drug discovery through innovations in chemical biology and machine learning. Recently, the GSK-Crick team received an EPSRC Prosperity Partnership grant to build a Systems Chemical Biology Platform that brings together reactive fragments, chemoproteomics, high-content biology and AI/ML. The platform is being applied in disease relevant models to expand the liganded proteome and generate insights into opportunities for therapeutic intervention.
Dr Nir London
The Alan and Laraine Fischer Career Development Chair @Weizmann Institute of Science
Recipient of the 2022 RSC Medicinal Chemistry Emerging Investigator Lectureship. Dr. Nir London completed his PhD in computational structural biology at the Hebrew University in 2012. He then pursued a post-doctoral fellowship with Brian Shoichet at UCSF where he developed a pioneering virtual screening platform for covalent inhibitor discovery. In 2015 Dr. London joined the Weizmann Institute of Science, where he is currently the Alan and Laraine Fischer Career Development Chair in the Dept. of Chemical and Structural Biology. Dr. London’s lab is focused on covalent chemical biology and drug discovery and is developing new technologies to discover and functionalize covalently acting compounds. His honors include amongst others the Alon fellowship, the EFMC award for young medicinal chemist in academia and the ICBS award for young chemical biologist.